Riskpilot← Back to searchSign inGet full accessFAGERSAND HELSE AS
ASActiveOrg 921482930Fagersandveien 12, 3124 TønsbergMedical specialists activities · NACE 8622Est. 20180 employees
Revenue 2024
NOK 0
EBITDA margin
—
-167% vs 2023
Equity ratio
6.0%
Financial strength
Net profit 2024
NOK -344K
-2014% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -138K | -167% |
| Net profit | NOK -344K | -2014% |
| Total assets | NOK 981K | -30% |
| Equity | NOK 59K | -85% |
| Employees | 0 | — |
Legal name
FAGERSAND HELSE AS
Org number
921482930
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
1. oktober 2018
Share capital
NOK 40 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene. Styrets leder alene.
Company purpose
Helsetjenester, behandling, forebygging av skader i bevegelsesapparatet & undervisning, samt alt som hører naturlig til dette.
Address
Fagersandveien 12, 3124 Tønsberg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 867 | 595 | 894 | 764 | 374 | 0 |
| Staff expenses | −0 | −1 | −0 | −11 | −16 | −1 | −1 |
| EBITDA | −39 | 655 | 348 | 235 | 382 | 205 | −138 |
| Depreciation & amort. | −0 | −7 | −14 | −32 | −13 | −7 | −100 |
| EBIT | −39 | 648 | 333 | 203 | 369 | 198 | −238 |
| Net financials | 0 | 0 | −146 | 0 | −0 | −0 | −107 |
| Profit before tax | −39 | 648 | 188 | 203 | 369 | 198 | −344 |
| Tax | −0 | 143 | 45 | −178 | 83 | 180 | −0 |
| Net profit | −39 | 506 | 143 | 382 | 286 | 18 | −344 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 34 | 638 | 865 | 1 057 | 1 377 | 1 409 | 981 |
| Equity | 34 | 215 | 198 | 379 | 425 | 403 | 59 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 423 | 667 | 677 | 952 | 1 005 | 922 |
| Total debt | 0 | 423 | 667 | 677 | 952 | 1 005 | 922 |
EBITDA margin
-13754400.0%
This company
15.8%
Market median
-87053265% vs market
20182024
Equity ratio
6.0%
This company
38.2%
Market median
-84% vs market
20182024
Return on equity
-584.0%
This company
18.4%
Market median
-3274% vs market
20182024
Net profit margin
-34435900.0%
This company
8.1%
Market median
-425134668% vs market
20182024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20182024
Debt / equity
15.64×
This company
0.62×
Market median
-2423% vs market
20182024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EM Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2018 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FAGERSAND HELSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Espen Møller-Hansen | Chief Executive Officer | 0 companies |
| Ingrid Møller-Hansen | Board of Directors | 0 companies |